Drug used for aggressive breast cancer on PBS from May 1st
The addition of the breast cancer drug Lapatinib (Tykerb) to the Pharmaceutical Benefits Scheme (PBS) means will mean cheaper access for Australian women with an advanced stage of breast cancer.